CD34 and neoplasm: There was no difference in MVD (assessed by CD34 immunostaining or by CD105 immunostaining) between tumors with high-intensity tumor budding and tumors with low-intensity or no tumor budding (p > 0.05; Tables 2 and 3; Fig. 1).